Concepedia
Statistics
Publications
6
Citations
1.5K
H-Index
Active since
2005
Affiliations
Moffitt Cancer Center(Current)
Novartis (United States)
University of South Florida
Merck & Co., Inc., Rahway, NJ, USA (United States)
Michael Pranpat is an author at Moffitt Cancer Center specializing in apoptosis, cell signaling, and mitochondrial function.
Top concepts
MedicineApoptosisCell DeathImmunologyCell BiologyPharmacologyCell SignalingDrug DiscoveryOxidative StressMedicinal Chemistry
Publications per year
2005–2006
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90
Purva Bali, Michael Pranpat, James E. Bradner et al. · Journal of Biological Chemistry · 2005 · 746 citations · Full text
Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin
Fei Guo, Kathy Rocha, Purva Bali et al. · Cancer Research · 2005 · 214 citations · Full text
Apoptosis, Immunology, Cell Death +18
Activity of Suberoylanilide Hydroxamic Acid Against Human Breast Cancer Cells with Amplification of Her-2
Purva Bali, Michael Pranpat, Ramona F. Swaby et al. · Clinical Cancer Research · 2005 · 186 citations · Full text
Combined effects of novel tyrosine kinase inhibitor AMN107 and histone deacetylase inhibitor LBH589 against Bcr-Abl–expressing human leukemia cells
Warren Fiskus, Michael Pranpat, Purva Bali et al. · Blood · 2006 · 146 citations · Full text
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells
Warren Fiskus, Michael Pranpat, Maria E. Balasis et al. · Molecular Cancer Therapeutics · 2006 · 112 citations
1–5 of 6